Form 4: Jonathan Lim, Director at Boundless Bio, Acquires Stock Options
SEC Form 4 Filing
Director Jonathan Lim acquired stock options in Boundless Bio, Inc. on June 20, 2024, under the company's 2024 Incentive Award Plan.
Summary
- On June 20, 2024, Jonathan Lim, a director at Boundless Bio, Inc., was granted stock options to purchase 6,610 shares of common stock.
- The options were granted under the Issuer's 2024 Incentive Award Plan.
- The exercise price of the options is $5.50 per share.
- The options vest in 36 substantially equal monthly installments starting on the first monthly anniversary of June 20, 2024, contingent upon continuous service to the Issuer.
- The expiration date for the options is June 19, 2034.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as the granting of stock options is a standard practice that aligns management interests with shareholders.
Positives
- The granting of stock options aligns the director's interests with those of the shareholders, incentivizing performance and company growth.
Future Outlook
The director's continued service will be required for the vesting of the stock options over the next 36 months.
Industry Context
Stock option grants are a common practice in the biotechnology industry to incentivize and retain key personnel, aligning their interests with the long-term success of the company.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for directors and executives in biotech companies.
- The vesting schedule of 36 months is typical for such grants, aligning with industry norms for incentivizing long-term commitment.
- Comparable companies like Relay Therapeutics or Revolution Medicines also utilize stock options as part of their executive compensation plans.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it incentivizes the director to work towards increasing shareholder value.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Date of earliest transaction: Grant of stock options. |
| 06/20/2024 | Stock option vests in 36 substantially equal monthly installments beginning on the first monthly anniversary of this date. |
| 06/19/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.